Abstract:Rhamnolipid, among the most effective biosurfactants, is a glycolipid‐type biosurfactant primarily produced by Pseudomonas aeruginosa. In this study, rhamnolipid production was carried out using a strain of P. aeruginosa and it is aimed to compare rhamnolipid biopolymers obtained from various extraction methods using glycine (RG), hydrochloric acid (RH), diethyl ether (RD), ethyl acetate (RE). Comparison analyses were performed through NMR, FTIR techniques and viscosity, density measurements apart from determi… Show more
“…The UHPLC method used was as described (Baidoo et al, 2019 ; Kim et al, 2021 ). For RL analysis, the cell pellets and supernatants were processed using an acidic (HCl) methanol/chloroform precipitation method described previously (Çakmak et al, 2017 ).…”
Rhamnolipids (RL) are well-studied biosurfactants naturally produced by pathogenic strains of Pseudomonas aeruginosa. Current methods to produce RLs in native and heterologous hosts have focused on carbohydrates as production substrate; however, methane (CH4) provides an intriguing alternative as a substrate for RL production because it is low-cost and may mitigate greenhouse gas emissions. Here we demonstrate RL production from CH4 by Methylotuvimicrobium alcaliphilum DSM19304. RLs are inhibitory to M. alcaliphilum growth (<0.05 g/L). Adaptive laboratory evolution was performed by growing M. alcaliphilum in increasing concentrations of RLs, producing a strain that grew in the presence of 5 g/L of RLs. Metabolomics and proteomics of the adapted strain grown on CH4 in the absence of RLs revealed metabolic changes, increase in fatty acid production and secretion, alterations in gluconeogenesis, and increased secretion of lactate and osmolyte products compared to the parent strain. Expression of plasmid borne RL production genes in the parent M. alcaliphilum strain resulted in cessation of growth and cell death. In contrast, the adapted strain transformed with the RL production genes showed no growth inhibition and produced up to 1 μM of RLs, a 600-fold increase compared to the parent strain, solely from CH4. This work has promise for developing technologies to produce fatty acid-derived bioproducts, including biosurfactants, from CH4.
“…The UHPLC method used was as described (Baidoo et al, 2019 ; Kim et al, 2021 ). For RL analysis, the cell pellets and supernatants were processed using an acidic (HCl) methanol/chloroform precipitation method described previously (Çakmak et al, 2017 ).…”
Rhamnolipids (RL) are well-studied biosurfactants naturally produced by pathogenic strains of Pseudomonas aeruginosa. Current methods to produce RLs in native and heterologous hosts have focused on carbohydrates as production substrate; however, methane (CH4) provides an intriguing alternative as a substrate for RL production because it is low-cost and may mitigate greenhouse gas emissions. Here we demonstrate RL production from CH4 by Methylotuvimicrobium alcaliphilum DSM19304. RLs are inhibitory to M. alcaliphilum growth (<0.05 g/L). Adaptive laboratory evolution was performed by growing M. alcaliphilum in increasing concentrations of RLs, producing a strain that grew in the presence of 5 g/L of RLs. Metabolomics and proteomics of the adapted strain grown on CH4 in the absence of RLs revealed metabolic changes, increase in fatty acid production and secretion, alterations in gluconeogenesis, and increased secretion of lactate and osmolyte products compared to the parent strain. Expression of plasmid borne RL production genes in the parent M. alcaliphilum strain resulted in cessation of growth and cell death. In contrast, the adapted strain transformed with the RL production genes showed no growth inhibition and produced up to 1 μM of RLs, a 600-fold increase compared to the parent strain, solely from CH4. This work has promise for developing technologies to produce fatty acid-derived bioproducts, including biosurfactants, from CH4.
“…Such methods are widely applied for both glycolipid type biosurfactants and high molecular weight bioemulsifier type compounds (Kourmentza et al ., 2019; Naughton et al ., 2019; Roelants et al ., 2019). When performing biosurfactant purification via liquid‐phase extraction followed by evaporation of the solvent or by precipitation of the compounds from broth or supernatant the end point is often an oily, honey‐like product (Roelants et al ., 2016; Çakmak et al ., 2017). These oily products typically also still contain up to 60 % water, which is mostly not determined and/or reported and thus results in an overestimation of the reported production.…”
Section: Process Development Towards the Scale‐up And Commercial Applmentioning
The demand for microbially produced surface‐active compounds for use in industrial processes and products is increasing. As such there has been a comparable increase in the number of publications relating to the characterisation of novel surface‐active compounds; novel producers of already characterised surface‐active compounds and production processes for the generation of these compounds. We devised this review as a guide to both researchers and the peer review process to improve the stringency of future studies and publications within this field of science.
“…Their hydrophilic moieties can be made of acid, cationic peptide, anion, sugar (monosaccharide, disaccharide, or polysaccharide) and hydrophobic moieties made of hydrocarbon or fatty acid chains. They are environmentally friendly and have been shown to have many industrial applications sometimes performing better than synthetic surfactants [3][4][5][6][7]. Their physico-chemical properties include; high stability in a wide range of environmental conditions such as extreme pH, temperature and also salt concentration [8,9], high biodegradability with a high rate of mineralization by soil microcosms [10], low toxicity, surface tension reduction, foaming capacity and antimicrobial activity against pathogens [11][12][13][14].…”
During 2020, the world has experienced extreme vulnerability in the face of a disease outbreak. The coronavirus disease 2019 (COVID-19) pandemic discovered in China and rapidly spread across the globe, infecting millions, causing hundreds of thousands of deaths, and severe downturns in the economies of countries worldwide. Biosurfactants can play a significant role in the prevention, control and treatment of diseases caused by these pathogenic agents through various therapeutic, pharmaceutical, environmental and hygiene approaches. Biosurfactants have the potential to inhibit microbial species with virulent intrinsic characteristics capable of developing diseases with high morbidity and mortality, as well as interrupting their spread through environmental and hygiene interventions. This is possible due to their antimicrobial activity, ability to interact with cells forming micelles and to interact with the immune system, and compatibility with relevant processes such as nanoparticle synthesis. They, therefore, can be applied in developing innovative and more effective pharmaceutical, therapeutics, sustainable and friendly environmental management approaches, less toxic formulations, and more efficient cleaning agents. These approaches can be easily integrated into relevant product development pipelines and implemented as measures for combating and managing pandemics. This review examines the potential approaches of biosurfactants as useful molecules in fighting microbial pathogens both known and previously unknown, such as COVID-19.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.